ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

About this update from Ani Pharmaceuticals, Inc.

PRINCETON, N.J. , May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani , Chief Executive Officer, and Stephen Carey , Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows: Date: Tuesday, May 20, 2025 Time: 1:30pm ET Webcast: Click Here To schedule a 1x1 meeting with management, please contact [email protected]. The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S. -based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com . Investor Relations: Lisa M. Wilson , In-Site Communications, Inc. T: 212-452-2793 E: [email protected] Source: ANI Pharmaceuticals, Inc. Source: ANI Pharmaceuticals, Inc.

View stock analysis, news, and events for Ani Pharmaceuticals, Inc.